Mariner
IBIO icon

Mariner’s iBio IBIO Stock Holding History

Mariner’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-45
Closed -$4K – 2782
2022
Q3 		$4K Buy
+45
New +$6.19K ﹤0.01% 2433

Other funds holding IBIO

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Mariner's IBIO Position: Q4 2022 in Review

Mariner sold out of iBio (IBIO) in Q4 2022, closing a stake of 45 shares — an estimated $4K sold.

Mariner first reported a position in IBIO in Q3 2022 and held it in 1 quarter. The position peaked at $4K in Q3 2022. 36 funds tracked by Wall St. Rank hold IBIO as of Q4 2022.

  • Mariner reported no remaining iBio position as of Q4 2022 after selling out during the quarter.
  • Mariner sold 45 iBio shares in Q4 2022, an estimated $4K.
  • Mariner first reported a position in iBio in Q3 2022 and held it in 1 quarter.
  • Mariner's iBio position peaked at $4K in Q3 2022.
  • 36 funds tracked by Wall St. Rank held iBio as of Q4 2022.

Based on Mariner's 13F filing for Q4 2022, filed 14 Feb 2023.